Anti-PCSK9 Recombinant Antibody (Lodelcizumab)
CAT#: TAB-758
Recombinant humanized antibody expressed in CHO binding to human PCSK9. Lodelcizumab is a monoclonal antibodiess for the treatment of hypercholesterolemia.
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Mouse
- Derivation
- Humanized (from mouse)
- Type
- IgG1 - kappa
- Species Reactivity
- Human
- Applications
- Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods.
- Generic Name
- lodelcizumab
- Related Disease
- Hypercholesterolemia
Product Property
- Purity
- >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
- Storage
- 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.
Target
Customer Review
There are currently no Customer reviews or questions for TAB-758. Click the button above to contact us or submit your feedback about this product.
Q&As
-
What is the purity of this Lodelcizumab antibody?
A: This recombinant antibody has a purity of greater than 97% as determined by SDS-PAGE under reducing conditions and visualized by silver stain. It is a humanized IgG1 kappa antibody expressed in CHO cells and is suitable for various immunological methods.
-
Can this antibody be used for functional assays?
A: Yes, this antibody is suitable for Functional Studies (FuncS), as well as ELISA, Flow Cytometry (FC), Immunoprecipitation (IP), Immunofluorescence (IF), Neutralization (Neut), and Immunocytochemistry (ICC). It binds to human PCSK9, a protein involved in cholesterol metabolism.
View the frequently asked questions answered by Creative Biolabs Support.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Protocol & Troubleshooting
We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.
See other products for "lodelcizumab"
Afuco™ Anti-PCSK9 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-758)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human PCSK9. It is a monoclonal antibodiess for the treatment of hypercholesterolemia.
See other products for "PCSK9"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1775z | Mouse Anti-PCSK9 Recombinant Antibody (clone 40B4) | WB, ELISA, IF, IP | Mouse IgG1, κ |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NABL-097 | Recombinant Anti-human PCSK9 VHH Single Domain Antibody | WB, ELISA, IHC, FC, FuncS | Llama VHH |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-H31 | Human Anti-PCSK9 Recombinant Antibody (TAB-H31) | FC, IP, ELISA, Neut, FuncS, IF, IHC | Human IgG2, λ |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-H10 | Anti-Human PCSK9 Recombinant Antibody (Bococizumab) | WB, FC, IP, ELISA, Neut, FuncS, IF | IgG2 - kappa |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-H59 | Anti-Human PCSK9 Recombinant Antibody (TAB-H59) | Neut, ELISA, IF, IP, FuncS, FC, ICC | IgG2 - kappa |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-764CL | Human Anti-PCSK9 Recombinant Antibody (TAB-764CL) | ELISA | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PABL-294 | Human Anti-PCSK9 Recombinant Antibody (clone mAb1) | WB, Block, FuncS | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PSBL-294 | Human Anti-PCSK9 Recombinant Antibody (clone mAb1); scFv Fragment | WB, Block, FuncS | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PFBL-294 | Human Anti-PCSK9 Recombinant Antibody (clone mAb1); Fab Fragment | WB, Block, FuncS | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PABZ-101 | Human Anti-PCSK9 Recombinant Antibody (clone 1D05) | ELISA, WB, Neut | Human IgG2 |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PABL-676 | Human Anti-PCSK9 Recombinant Antibody (PABL-676) | WB, FuncS | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PABL-677 | Mouse Anti-PCSK9 Recombinant Antibody (clone mAb J16) | WB, ELISA, FuncS | Mouse IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PFBZ-101 | Human Anti-PCSK9 Recombinant Antibody (clone 1D05); Fab Fragment | ELISA, WB, Neut | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PFBL-670 | Human Anti-PCSK9 Recombinant Antibody; Fab Fragment (PFBL-670) | WB, FuncS | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PFBL-671 | Mouse Anti-PCSK9 Recombinant Antibody (clone mAb J16); Fab Fragment | WB, ELISA, FuncS | Mouse Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PFBL-672 | Human Anti-PCSK9 Recombinant Antibody (clone CBL36Q); Fab Fragment | ELISA, WB | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PSBZ-101 | Human Anti-PCSK9 Recombinant Antibody (clone 1D05); scFv Fragment | ELISA, WB, Neut | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PSBL-670 | Human Anti-PCSK9 Recombinant Antibody; scFv Fragment (PSBL-670) | WB, FuncS | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PSBL-671 | Mouse Anti-PCSK9 Recombinant Antibody (clone mAb J16); scFv Fragment | WB, ELISA, FuncS | Mouse scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PSBL-672 | Human Anti-PCSK9 Recombinant Antibody (clone CBL51Q); scFv Fragment | ELISA, WB | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0020CL | Anti-Human PCSK9 Recombinant Antibody (LPD1282/LPD1462 {i.e., antibody 1 F11)) | LDL-c uptake assay | Humanized Antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0953CL | Human Anti-PCSK9 Recombinant Antibody (TAB-0953CL) | ELISA | Human IgG1 |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0954CL | Human Anti-PCSK9 Recombinant Antibody (TAB-0954CL) | WB | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0955CL | Mouse Anti-PCSK9 Recombinant Antibody (TAB-0955CL) | WB | Mouse IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0956CL | Anti-Human PCSK9 Recombinant Antibody (m7F8) | ELISA |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0957CL | Anti-Human PCSK9 Recombinant Antibody (h7F8) | ELISA | Humanized antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0959CL | Human Anti-PCSK9 Recombinant Antibody (TAB-0959CL) | ELISA, FC | Human antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0960CL | Anti-Human PCSK9 Recombinant Antibody (Ab1) | ELISA | Rabbit mAb |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0956CL-S(P) | Anti-Human PCSK9 Recombinant Antibody scFv Fragment (m7F8) | ELISA |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0960CL-S(P) | Anti-Human PCSK9 Recombinant Antibody scFv Fragment (Ab1) | ELISA | Rabbit mAb |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0956CL-F(E) | Anti-Human PCSK9 Recombinant Antibody Fab Fragment (m7F8) | ELISA |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0080CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (TAB-0080CL-VHH) | FuncS, Inhib, FC, WB | Single domain antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0081CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (TAB-0081CL-VHH) | FuncS, Inhib, FC, WB | Single domain antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0082CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (TAB-0082CL-VHH) | FuncS, Inhib, FC, WB | Single domain antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0083CL-VHH | Anti-Human PCSK9 VHH Single Domain Antibody (TAB-0083CL-VHH) | FuncS, Inhib, FC, WB | Single domain antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NEUT-1826CQ | Recombinant Human Anti-PCSK9 Antibody, Unconjugated | Neut | IgG1 |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOR-2618 | Hi-Affi™ Recombinant Rabbit Anti-PCSK9 Monoclonal Antibody (DS2618AB) | WB | IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-758 | Afuco™ Anti-PCSK9 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-758) | ELISA, FC, IP, FuncS, IF, Neut | ADCC enhanced antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-H10 | Afuco™ Anti-PCSK9 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H10) | FC, IP, ELISA, Neut, FuncS | ADCC enhanced antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-H59 | Afuco™ Anti-PCSK9 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H59) | Neut, ELISA, IF, IP, FuncS, FC | ADCC enhanced antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-H31 | Afuco™ Anti-PCSK9 Recombinant Antibody (AFC-TAB-H31), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS, IF | Human IgG1, λ |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0424-XY208 | AbPlus™ Anti-PCSK9 Magnetic Beads (VS-0424-XY208) | IP, Protein Purification |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0325-FY208 | Human Anti-PCSK9 scFv-Fc Chimera (VS-0325-FY208) | WB, Block | Human IgG1, scFv-Fc |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0525-XY5250 | Anti-PCSK9 Immunohistochemistry Kit | IHC |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0525-YC142 | Recombinant Anti-PCSK9 (AA 31-152 x AA 213-219) Biparatopic Antibody, Tandem scFv (Clone 6E2 x Clone 3D5) | ELISA | Tandem scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0625-YC248 | Recombinant Anti-PCSK9 Eliminating Antibody, pH-Sensitive (VS-0625-YC248) | Antigen-Sweeping In Vivo. | Human IgG2 kappa |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0825-YC18 | SmartAb™ Recombinant Anti-PCSK9 pH-dependent Antibody (Clone Bococizumab) | WB, FC, IP, ELISA, Neut, IF | Human IgG2 kappa |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0825-YC20 | SmartAb™ Recombinant Anti-PCSK9 pH-dependent Antibody (Clone J19) | IF, IP, WB, ELISA | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0825-YC277 | SmartAb™ Recombinant Anti-PCSK9 pH-dependent Antibody (Clone Lodelcizumab) | ELISA, FC, IP IF, Neut, ICC | Human IgG1 kappa |
Popular Products

Application: IF, IP, Neut, FuncS, ELISA, FC, ICC

Application: WB, IHC, ELISA, FC

Application: ELISA, IHC, FC, IP, IF, Inhib

Application: ELISA, IHC, FC, IP, IF, FuncS

Application: ELISA, FC, Neut, Inhib

Application: ELISA, Block, WB, FC, IP
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


















